N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Arthritis & Rheumatism

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/art.34502PMID 22549432PMCID PMC3411859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BLISS! Lupus learns its lessons.

  2011cited by this paper
• Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus

  2011cited by this paper
• Biologics in the treatment of systemic lupus erythematosus

  2010cited by this paper
• mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?

  2010cited by this paper
• The impact of flare on disease costs of patients with systemic lupus erythematosus.

  2009cited by this paper
• Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation1

  2009cited by this paper
• Pharmacotherapy of systemic lupus erythematosus

  2009cited by this paper
• Metabolic control of T cell activation and death in SLE.

  2009cited by this paper
• Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1

  2008cited by this paper
• Diurnal variation in glutathione and cysteine redox states in human plasma.

  2007cited by this paper
• Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1

  2007cited by this paper
• N-acetyl-cysteine abolishes hydrogen peroxide-induced modification of eukaryotic initiation factor 4F activity via distinct signalling pathways.

  2006cited by this paper
• Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1

  2006cited by this paper
• Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.

  2006cited by this paper
• Immune cells and cytokines in systemic lupus erythematosus: an update

  2005cited by this paper
• Development and initial validation of an updated version of the British Isles Lupus Assessment Group ’ s disease activity index for patients with systemic lupus erythematosus

  2005cited by this paper
• The Therapeutic Use of Acetaminophen in Patients with Liver Disease

  2005cited by this paper
• High-dose acetylcysteine in idiopathic pulmonary fibrosis.

  2005cited by this paper
• Nitric Oxide-Dependent Mitochondrial Biogenesis Generates Ca2+ Signaling Profile of Lupus T Cells

  2004cited by this paper
• Quantification of regulatory T cells in patients with systemic lupus erythematosus.

  2003cited by this paper
• Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale.

  2003cited by this paper
• Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.

  2002cited by this paper
• Antioxidants suppress mortality in the female NZB × NZW F1 mouse model of systemic lupus erythematosus (SLE)

  2001cited by this paper
• Modulation of endogenous glutathione availability.

  1999cited by this paper
• Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

  1997cited by this paper
• Effect of N-acetylcysteine on human diaphragm strength and fatigability.

  1997cited by this paper
• Glutathione deficiency is associated with impaired survival in HIV disease.

  1997cited by this paper
• Glutathione Levels and Sensitivity to Apoptosis Are Regulated by Changes in Transaldolase Expression*

  1996cited by this paper
• Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus.

  1994cited by this paper
• Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

  1992cited by this paper
• A study of fatigue in systemic lupus erythematosus.

  1990cited by this paper
• T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.

  1989cited by this paper

• Metabolic traits of T cells and the implications in autoimmune diseases.

  2026cites this paper
• Association Between the Fatigue Assessment Scale and Clinical Indices in Patients With Systemic Lupus Erythematosus

  2026influential citation
• Transaldolase deficiency – natural disease course towards adulthood

  2026cites this paper
• The metabolic landscape of connective tissue diseases: Applications and discoveries in metabolomics research.

  2025cites this paper
• NETs: a new target for autoimmune disease

  2025cites this paper
• Endosome traffic in rheumatic diseases: mechanistic insights and therapeutic opportunities

  2025cites this paper
• Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases.

  2025cites this paper
• Energy metabolism in health and diseases

  2025cites this paper
• Targeting the ROS-ferroptosis axis: A clinical perspective on oxidative stress management in systemic lupus erythematosus.

  2025cites this paper
• GNS561 (ezurpimtrostat), a small basic lipophilic molecule, prevents lupus phenotype in a pristane‐induced lupus mouse model

  2025cites this paper
• Experiences and unmet needs of persons living with systemic lupus erythematosus in Europe: Lupus Europe's 2024 Swiss knife survey.

  2025cites this paper
• Neutrophil Extracellular Traps in Systemic Lupus Erythematosus: Pathogenic Mechanisms, Crosstalk with Oxidative Stress, and Antioxidant Therapeutic Potential

  2025cites this paper
• The Pathophysiological Role of Mitochondrial Oxidative Stress in Rheumatic Diseases

  2025influential citation
• Aberrant glucose metabolism drives dysfunction of CD4+ T cells in systemic lupus erythematosus and disease flares

  2025cites this paper
• Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren's disease.

  2025cites this paper
• Iron Metabolism and Ferroptosis: Druggable Targets to Delay the Progression of Lupus Nephritis.

  2025cites this paper
• Endometriosis and autoimmunity.

  2025cites this paper
• Metabolic reprogramming as a therapeutic target for modulating the Th17/Treg balance in autoimmune diseases: a comprehensive review

  2025cites this paper
• Overview of Oxidative Stress in Systemic Lupus Erythematosus

  2025cites this paper
• Immunometabolic modulators alleviate vascular dysfunction in mice with systemic lupus erythematosus.

  2025cites this paper
• Gluconolactone restores immune regulation and alleviates skin inflammation in lupus-prone mice and in patients with cutaneous lupus.

  2025cites this paper
• Ferroptosis in immune chaos: Unraveling its impact on disease and therapeutic potential

  2025cites this paper
• Anti-Tumoral Treatment with Thioredoxin Reductase 1 Inhibitor Auranofin Fosters Regulatory T Cell and B16F10 Expansion in Mice

  2025cites this paper
• THE POTENTIAL ROLE OF METFORMIN IN THE TREATMENT OF HASHIMOTO’S THYROIDITIS: REVIEW

  2025cites this paper
• The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases

  2025cites this paper
• Advances in the treatment of systemic lupus erythematosus

  2025influential citation
• Anti-PS IgG Immune Complexes Impair Macrophage Phagocytosis in SLE via LOX-Dependent Oxidative Stress

  2025cites this paper
• Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases

  2025cites this paper
• The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis.

  2025cites this paper
• Exploring the shared mechanism of fatigue between systemic lupus erythematosus and myalgic encephalomyelitis/chronic fatigue syndrome: monocytic dysregulation and drug repurposing

  2025cites this paper
• Molecular and therapeutic landscape of ferroptosis in skin diseases

  2024cites this paper
• Redox Pathogenesis in Rheumatic Diseases

  2024cites this paper
• The immunology of systemic lupus erythematosus

  2024cites this paper
• UBQLN1 links proteostasis and mitochondria function to telomere maintenance in human embryonic stem cells

  2024cites this paper
• Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications.

  2024cites this paper
• Efficacy of N-Acetylcysteine as an Adjuvant Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

  2024cites this paper
• Mitochondria dysfunction: A trigger for cardiovascular diseases in systemic lupus erythematosus.

  2024cites this paper
• Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential

  2024cites this paper
• The role of mitochondrial dysfunction in kidney injury and disease.

  2024cites this paper
• Metabolic regulation of the immune system in health and diseases: mechanisms and interventions

  2024cites this paper
• Navigating the metabolic landscape of regulatory T cells: from autoimmune diseases to tumor microenvironments.

  2024cites this paper
• Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus.

  2024cites this paper
• Potential therapies targeting metabolic pathways in systemic lupus erythematosus.

  2024cites this paper
• T cell involvement in antiphospholipid syndrome.

  2024cites this paper
• Metabolic Plasticity of Regulatory T Cells in Health and Autoimmunity.

  2024cites this paper
• Immmunometabolism of systemic lupus erythematosus.

  2024cites this paper
• Exploring the ROS reduction strategies in chronic lupus management

  2024cites this paper
• Metabolic dysregulation of lymphocytes in autoimmune diseases.

  2024cites this paper
• Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases.

  2024cites this paper
• N-Acetylcysteine Inhibits Coxsackievirus B3 Replication by Downregulating Eukaryotic Translation Elongation Factor 1 Alpha 1

  2024cites this paper
• Double-Negative T (DNT) Cells in Patients with Systemic Lupus Erythematosus

  2024cites this paper
• Functional consequence of Iron dyshomeostasis and ferroptosis in systemic lupus erythematosus and lupus nephritis.

  2024cites this paper
• Emerging biologic therapies for systemic lupus erythematosus

  2024cites this paper
• Exploring the Role of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus: A Clinical Case Study and Comprehensive Review

  2024cites this paper
• Redox mechanisms in autoimmune thyroid eye disease.

  2024cites this paper
• Ironing out the role of ferroptosis in immunity.

  2024cites this paper
• New and emerging therapies for systemic lupus erythematosus.

  2024cites this paper
• Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis

  2024cites this paper
• Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation

  2024cites this paper
• Mitochondrial aberrations in systemic lupus erythematosus pathogenesis: Insights and therapeutic implications

  2024cites this paper
• Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions.

  2023cites this paper
• Activated Lymphocyte-Derived DNA Drives Glucose Metabolic Adaptation for Inducing Macrophage Inflammatory Response in Systemic Lupus Erythematosus

  2023cites this paper
• Model of the systemic lupus erythematosus pathogenesis based on an autoimmune response to mitochondrial components

  2023cites this paper
• Oxidized galectin-1 in SLE fails to bind the inhibitory receptor VSTM1 and increases reactive oxygen species levels in neutrophils

  2023cites this paper
• Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus

  2023cites this paper
• Increasing glutathione levels by a novel posttranslational mechanism inhibits neuronal hyperexcitability

  2023cites this paper
• Pharmacologic inhibition of glycolysis prevents the development of lupus by altering the gut microbiome in mice

  2023cites this paper
• Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19

  2023cites this paper
• A cellular overview of immunometabolism in systemic lupus erythematosus

  2023cites this paper
• Transcriptional and metabolic programs promote the expansion of follicular helper T cells in lupus-prone mice

  2023cites this paper
• Differential impact of environmental factors on systemic and localized autoimmunity

  2023cites this paper
• Abnormal mTOR Signaling Pathway Activity in Autism Spectrum Disorders: Prospects of Mechanism-Based Therapy

  2023cites this paper
• Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry

  2023cites this paper
• Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: a randomized double-blind clinical trial study

  2023cites this paper
• Oxidative Stress Contributes to Inflammatory and Cellular Damage in Systemic Lupus Erythematosus: Cellular Markers and Molecular Mechanism

  2023cites this paper
• Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4+ T Cells—Implications for the Pathogenesis of Systemic Lupus Erythematosus

  2023cites this paper
• Does the use of cysteine-rich whey protein supplements (Inmunocal®) improve the health well-being of COVID-19 patients? A qualitative study

  2023cites this paper
• T regulatory cells metabolism: The influence on functional properties and treatment potential

  2023cites this paper
• Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases

  2023cites this paper
• The role of NETosis in the pathogenesis of immunoinflammatory rheumatic diseases

  2023cites this paper
• Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery

  2023cites this paper
• α‐Ketoglutarate–Dependent KDM6 Histone Demethylases and Interferon‐Stimulated Gene Expression in Lupus

  2023cites this paper
• Oxidative Stress as a Regulatory Checkpoint in the Production of Antiphospholipid Autoantibodies: The Protective Role of NRF2 Pathway

  2023cites this paper
• Nutritional Approaches to Modulate Cardiovascular Disease Risk in Systemic Lupus Erythematosus: A Literature Review

  2023cites this paper
• Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus

  2023cites this paper
• Ferroptosis: A potential therapeutic target in autoimmune disease (Review)

  2023influential citation
• T Lymphocyte Metabolic Features and Techniques to Modulate Them

  2023cites this paper
• Editorial: Mitochondrial dysfunction in inflammation and autoimmunity

  2023cites this paper
• Nutrients and Botanical Medicines in Systemic Lupus Erythematosus

  2023cites this paper
• Neutrophil, NETs and Behçet's disease: A review.

  2023cites this paper
• Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development

  2022cites this paper
• Hallmarks of cancer and hallmarks of aging

  2022cites this paper
• The role of N-acetyl cysteine and some other clinical antidotes in the treatment of patients with COVID-19; review of the current evidence

  2022cites this paper
• CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy

  2022cites this paper
• Animal models of systemic lupus erythematosus and their applications in drug discovery

  2022cites this paper
• T cell metabolism and possible therapeutic targets in systemic lupus erythematosus: a narrative review

  2022cites this paper
• Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?

  2022cites this paper
• Glycolysis in Innate Immune Cells Contributes to Autoimmunity

  2022cites this paper
• Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus

  2022cites this paper
• The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus

  2022cites this paper